menu

CME: Bleeding Disorders and Female Patients: Emerging Options in Hemostasis

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Bleeding Disorders and Female Patients: Emerging Options in Hemostasis

close
0.25 credits
15 Minutes
Bleeding Disorders and Female Patients: Emerging Options in Hemostasis
Restart
Resume
Choose a format
Get your free creditsSkip straight to the post-test if you have already participated in this activity
Media formats available:
Details
Presenters
Comments
  • Overview

    Women with bleeding disorders, including those with hemophilia and other rare inherited bleeding disorders, are disproportionately affected by bleeding than men due to menstruation and pregnancy. However, evidence suggests that many Ob/Gyns have difficulty recognizing potential bleeding disorders and find the management of bleeding disorders in their patients challenging, particularly when they present with menorrhagia or bleeding complications during pregnancy, childbirth, and the postpartum period.

    To help Ob/Gyns overcome these challenges, this activity will identify the signs and symptoms that should raise suspicion of a bleeding disorder and discuss management strategies for female patients with bleeding disorders, particularly menorrhagia and disorders during pregnancy and childbirth. 

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Andrea J. Singer, MD, FACP, CCD
    Director, Women's Primary Care
    Director, Bone Densitometry
    Department of Obstetrics and Gynecology
    MedStar Georgetown University Hospital
    Washington, DC


    Consulting Fees: AgNovos, Amgen, Eli Lilly, Radius, UCB
    Speaker Bureau: Amgen, Radius, TherapeuticsMD
    Contracted Research: Radius Health, UCB 

    Faculty:
    Sanjay P. Ahuja, MD, MSc, MBA
    Director, UH Rainbow Hemostasis & Thrombosis Center
    Rainbow Babies & Children’s Hospital
    Cleveland, OH


    Consulting Fees: HEMA Biologics, Sanofi, XaTek, Inc.
    Contracted Research: XaTek, Inc. 

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Stephen Chavez has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Identify the signs and symptoms that should raise suspicion of a bleeding disorder to engage patients in shared decision-making regarding possible implications of such conditions for women’s health and family planning, including prompt and appropriate referral for management
    • Incorporate evidence-based, multidisciplinary, and interprofessional management strategies for female patients with bleeding disorders, particularly menorrhagia and disorders during pregnancy and childbirth, to optimize safety
    • Describe the mechanisms of action of new and emerging treatment options in rebalancing hemostasis
  • Target Audience

    This activity is designed to meet the educational needs of Ob/Gyns, primary care physicians, family practitioners and other providers who treat and manage female patients suspected of having bleeding disorders.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Novo Nordisk.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Women with bleeding disorders, including those with hemophilia and other rare inherited bleeding disorders, are disproportionately affected by bleeding than men due to menstruation and pregnancy. However, evidence suggests that many Ob/Gyns have difficulty recognizing potential bleeding disorders and find the management of bleeding disorders in their patients challenging, particularly when they present with menorrhagia or bleeding complications during pregnancy, childbirth, and the postpartum period.

    To help Ob/Gyns overcome these challenges, this activity will identify the signs and symptoms that should raise suspicion of a bleeding disorder and discuss management strategies for female patients with bleeding disorders, particularly menorrhagia and disorders during pregnancy and childbirth. 

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Andrea J. Singer, MD, FACP, CCD
    Director, Women's Primary Care
    Director, Bone Densitometry
    Department of Obstetrics and Gynecology
    MedStar Georgetown University Hospital
    Washington, DC


    Consulting Fees: AgNovos, Amgen, Eli Lilly, Radius, UCB
    Speaker Bureau: Amgen, Radius, TherapeuticsMD
    Contracted Research: Radius Health, UCB 

    Faculty:
    Sanjay P. Ahuja, MD, MSc, MBA
    Director, UH Rainbow Hemostasis & Thrombosis Center
    Rainbow Babies & Children’s Hospital
    Cleveland, OH


    Consulting Fees: HEMA Biologics, Sanofi, XaTek, Inc.
    Contracted Research: XaTek, Inc. 

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Stephen Chavez has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Identify the signs and symptoms that should raise suspicion of a bleeding disorder to engage patients in shared decision-making regarding possible implications of such conditions for women’s health and family planning, including prompt and appropriate referral for management
    • Incorporate evidence-based, multidisciplinary, and interprofessional management strategies for female patients with bleeding disorders, particularly menorrhagia and disorders during pregnancy and childbirth, to optimize safety
    • Describe the mechanisms of action of new and emerging treatment options in rebalancing hemostasis
  • Target Audience

    This activity is designed to meet the educational needs of Ob/Gyns, primary care physicians, family practitioners and other providers who treat and manage female patients suspected of having bleeding disorders.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Novo Nordisk.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 3/31/20